Clinical Trials Epilepsy Policy Seed-To-Sale 
Project CBD
FEBRUARY 28, 2023
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. E-commerce sales of CBD in the U.S. increase in annual sales.
Canna Law Blog
OCTOBER 5, 2022
We could see medical marijuana in Japan in the near future, which would be huge for Asian cannabis policy and the world. Passed in 1948, Japan’s Cannabis Control Act bans the import, export, production, sale, possession, and research of marijuana. Yes, medical marijuana could finally be coming to Japan. Similar to how the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
AUGUST 19, 2021
Such products will generate sales of £690 million ($856 million, 811 million euros) in 2021, according to the Association for the Cannabinoid Industry (ACI). Faced with booming sales, professor Sagnik Bhattacharyya, who researches psychotic and substance abuse disorders at King’s College London, says clinical trials are needed.
Veriheal
MARCH 23, 2023
The report states that the revision is an essential move for ensuring the legal use of cannabis-derived epilepsy drug Epidiolex , which is currently being reviewed as part of a series of clinical trials in Japan. On Tuesday, January 24, several legislative bills were unveiled by the Japanese government. ‘1948 Law No.
Cannabis Law Report
OCTOBER 17, 2019
As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. Selinger cites software, point-of-sale systems, and packaging as areas that are thriving in the state.
Expert insights. Personalized for you.
144 
Let's personalize your content